Literature DB >> 7327977

Pulmonary hypertension induced by repeated pulmonary inflammation in the rat.

J Herget, F Palecek, P Preclík, M Cermáková, M Vízek, M Petrovická.   

Abstract

The effect of repeated lung inflammation on the pulmonary vascular bed was studied in rats. Nonbacterial lung inflammation was induced by repeated carrageenan instillations into the lungs. Three days after the single carrageenan injection, the mean pulmonary arterial blood pressure was only slightly raised [16.3 +/- 0.6 (mean +/- SE) Torr in controls and 19.5 +/- 0.5 Torr in rats with lung inflammation, P less than 0.001]. A substantial pulmonary hypertension was found in rats 3 days after the sixth lung inflammation (24.6 +/- 1 Torr). In this group, arterial hypoxemia, hypercapnia, and right-heart hypertrophy were found. In the 14th day of recovery after the last injection of carrageenan, the mean pulmonary artery blood pressure decreased (18.5 +/- 0.9 Torr) but remained higher than in the control group. There was no difference in cardiac output measured by dye-dilution technique between the experimental and control groups. After repeated inflammation, the media of distal pulmonary vessels thickened and the number of pulmonary arterioles with distinct media increased.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7327977     DOI: 10.1152/jappl.1981.51.3.755

Source DB:  PubMed          Journal:  J Appl Physiol Respir Environ Exerc Physiol        ISSN: 0161-7567


  7 in total

1.  Emergence of fibroblasts with a proinflammatory epigenetically altered phenotype in severe hypoxic pulmonary hypertension.

Authors:  Min Li; Suzette R Riddle; Maria G Frid; Karim C El Kasmi; Timothy A McKinsey; Ronald J Sokol; Derek Strassheim; Barbara Meyrick; Michael E Yeager; Amanda R Flockton; B Alexandre McKeon; Douglas D Lemon; Todd R Horn; Adil Anwar; Carlos Barajas; Kurt R Stenmark
Journal:  J Immunol       Date:  2011-08-03       Impact factor: 5.422

2.  Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension.

Authors:  R M Tuder; B Groves; D B Badesch; N F Voelkel
Journal:  Am J Pathol       Date:  1994-02       Impact factor: 4.307

Review 3.  The structural basis of pulmonary hypertension in chronic lung disease: remodelling, rarefaction or angiogenesis?

Authors:  Natalie Hopkins; Paul McLoughlin
Journal:  J Anat       Date:  2002-10       Impact factor: 2.610

4.  Role of the CX3CL1-CX3CR1 axis in chronic inflammatory lung diseases.

Authors:  Jianliang Zhang; Jawaharlal M Patel
Journal:  Int J Clin Exp Med       Date:  2010-08-10

Review 5.  Pulmonary hypertension survival effects and treatment options in cystic fibrosis.

Authors:  Adriano R Tonelli
Journal:  Curr Opin Pulm Med       Date:  2013-11       Impact factor: 3.155

6.  Fatty acid transduction of nitric oxide signaling: nitrolinoleic acid mediates protective effects through regulation of the ERK pathway.

Authors:  Karen E Iles; Marcienne M Wright; Marsha P Cole; Nathan E Welty; Lorraine B Ware; Michael A Matthay; Francisco J Schopfer; Paul R S Baker; Anupam Agarwal; Bruce A Freeman
Journal:  Free Radic Biol Med       Date:  2008-12-14       Impact factor: 7.376

7.  A Novel Peptide for Immunomodulation in Pulmonary Arterial Hypertension.

Authors:  Daniel Grinnan; Laszlo Farkas
Journal:  Am J Respir Crit Care Med       Date:  2019-06-15       Impact factor: 21.405

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.